Integrated analysis identifies S100A16 as a potential prognostic marker for pancreatic cancer

CONCLUSION: S100A16 is a potential independent prognostic marker and immunotherapy target for PC. Mechanistically, S100A16 potentially affects prognosis by extensive immunosuppression, including the inhibition of the anti-tumor immune response of CD8+ T cells.PMID:34150181 | PMC:PMC8205789

Source: American Journal of Translational Research - June 21, 2021 Category: Research Authors: Tian Chen De-Meng Xia Chao Qian Shan-Rong Liu Source Type: research